Winton Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Winton Group’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-62,942	Closed	-$1.1M	–	1483
2020 Q4	$1.1M	Sell	62,942 -85,478	-58%	-$1.2M	0.08%	354
2020 Q3	$1.74M	Sell	148,420 -26,158	-15%	-$347K	0.06%	601
2020 Q2	$2.27M	Buy	174,578 +89,072	+104%	+$1.07M	0.06%	592
2020 Q1	$792K	Buy	85,506 +15,598	+22%	+$218K	0.02%	887
2019 Q4	$1.16M	Sell	69,908 -4,837	-6%	-$78.4K	0.02%	1011
2019 Q3	$1.24M	Buy	+74,745	New	+$1.03M	0.01%	740

Winton Group's OXFD Position: Q1 2021 in Review

Winton Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 62,942 shares — an estimated $1.1M sold.

Winton Group first reported a position in OXFD in Q3 2019 and held it in 6 quarters. The position peaked at $2.27M in Q2 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Winton Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Winton Group sold 62,942 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.1M.
Winton Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2019 and held it in 6 quarters.
Winton Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.27M in Q2 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Winton Group's 13F filing for Q1 2021, filed 21 Jul 2021.